Skip to content

Clinical trial for the efficacy and safety of paste type acellular dermal matrix in chronic wound healing.

Clinical trial for the efficacy and safety of paste type acellular dermal matrix in chronic wound healing.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003027
Enrollment
90
Registered
2018-07-25
Start date
2017-09-19
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Seoul Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - adults over 19 years - Dermal defect from skin defect in Full-thickness skin to bone exposure level after debriment in wound area - chronic wounds that have not been healed despite adequate treatment for more than 3 weeks after wounds - At the time of the study, patients with a wound size of 4 cm2 or more

Exclusion criteria

Exclusion criteria: - Patients with superficial or partial thickness skin defect - Patient with osteomyelitis - Undermining wound, tunneling wound which can not measure the exact depth (can participate if open wound due to debriment) - Patients who exceeded 12% of HbA1C within 3 months before participating in the study - Patients with a serum creatinine concentration of 3.0 mg/dL or more within 30 days before participating in the study - Patients who have applied other medical devices and growth factors for wound healing within 30 days before participating in the study - Patients with wound infections (available after infection treatment)

Design outcomes

Primary

MeasureTime frame
At the start of treatment by each group Wound size reduction rate(%) after 12 weeks compared to wound size

Secondary

MeasureTime frame
wound closure rate;The period to complete wound closure;The changes in the level of tissue exposed (divided into partial thickness skin, full thickness skin, subQ, deep fascia, muscle, tendon, bone);adverse events

Countries

Korea, Republic of

Contacts

Public ContactYounhwan Kim

Hanyang University Seoul Hospital

younhwank@daum.net+82-2-2290-8560

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026